ASCO-GU – Pfizer looks for bigger bladder cancer invasion
Padcev still looks good in first-line bladder, but Pfizer hopes to make a mark in muscle-invasive disease.
Padcev still looks good in first-line bladder, but Pfizer hopes to make a mark in muscle-invasive disease.
